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Article points 
 
1. Local Enhanced Services (LESs) for diabetes have been commissioned across the UK to address 
local needs in diabetes care. 
2. Evaluation of the short- and long-term impact of diabetes LESs is lacking. This hinders learning 
within and beyond the commissioned service. 
3. The success of a LES depends on the level of readiness and preparedness of primary care to com-
mit time and resources. 
4. A LES can play an important role as a short-term catalyst, but there is no readily accessible infor-
mation on what happens to incentivise practice when it is withdrawn. 
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Abstract 
 
The Local Enhanced Service (LES) is a popular commissioning tool to boost the quality of health care. 
Primary care providers are invited to participate in the LES and offered financial incentives. There 
are many LESs for Diabetes across the UK, creating opportunities for comparing their variation in 
content and determining best practice. However, little is known about the individual LESs and their 
outcomes. Calling on mostly unpublished Clinical Commissioning Groups’ documents, this paper dis-
cusses the current practice in Diabetes LESs and highlights a need for their systematic evaluation.  
 
Introduction  
 
GP services in England are contracted to provide core (essential) and additional services to their 
patients. Where the provision of primary medical services have been agreed on top of these ser-
vices, they are called Enhanced Services. They may be used to fill in a gap in core services or to 
deliver core services to a higher than specified standard. As such, they provide opportunities to 
improve clinical and process outcomes in local health services. There are three types of Enhanced 
Service, depending on how the service is commissioned and what it is commissioned for: directed 
enhanced services, LESs and local improvement schemes. This article focuses on the local enhanced 
service and its effectiveness in addressing locally identified needs. 
 
In the process of developing a LES for diabetes for Oxfordshire Clinical Commissioning Group (CCG), 
a lack of information about what constitutes an effective local enhanced service for diabetes was 
identified. In particular, what intervention is taken up quickly by GP practices and what makes a 
successful LES. Our analysis adds to the literature that identifies a need for understanding the pro-
cesses by which financial incentives influence care (Jackson et al, 2017; Mandavia et al, 2017). A 
search for evidence highlighted the lack of good quality information available on the characteristics 
and outcomes of concluded LESs for diabetes, perhaps because LESs are local initiatives, responding 
to a local need. However, since a LES boosts core services, there are likely to be similarities in local 
needs across the NHS. Knowing what interventions are successful would be invaluable for others to 
build on when distributing limited resources. 
 
What is a Local Enhanced Service  
 
Before 2012, there were three types of enhanced services. When the Health and Social Care Act 
2012 came into force in 2013, the arrangements became:  
1. Directed enhanced services (DES). Nationally commissioned through GP contracts by NHS Eng-
land, with national specifications and benchmarked pricing.  
2. Local enhanced services:  
a. Community-based services. Locally commissioned to reflect needs and priorities.  
b. Transitional local enhanced services. Responsibility for LESs that had not expired on or before 31 
March 2013 was transferred to NHS England, which delegated the management of these services 
and associated funds to CCGs. CCGs can review these LESs and decide if they wish to invest these 
funds in the current services or in alternative community-based services.  
3. Local improvement schemes. Resources used from the CCG budget to pay for improvements in 
services provided under the GP contract or to support activities such as clinical audit or peer review. 
CCGs do not have powers in their own right to pay for improvements in services provided under the 
GP contract and can apply to the relevant NHS England area team for delegated powers to use their 
budget (NHS Commissioning Board, 2012; British Medical Association, 2016). 
 
Across the UK and for a number of health conditions, LESs have been used for a variety of purposes, 
including (adapted from Kumar et al, 2014):  
•  Improving access to specialist care.  
•  Improving identification of patients with undiagnosed disease.  
•  Improving patients’ engagement with healthcare and adherence to treatment.  
•  Increasing primary care capability.  
•  Improving disease management.  
• Improving care in care homes. 
 
The use of a local enhanced service in diabetes commissioning  
 
An overview of the content of a LES for diabetes  
 
The review of LESs for diabetes was complicated as there is no national database with reports of 
concluded LESs. The only way to collect this information is to contact every commissioner. This was 
done in 2010 when 147 Primary Care Trusts (PCTs) in England were approached, with 63 responding, 
26 of which confirmed using LES (Gadsby and Khunti, 2013). Three types of services were reported 
as commissioned: insulin initiation and follow-up, oral glucose tolerance testing in practice and glu-
cagon-like peptide-1 initiation in practice. In the first, payments ranged from £80–£200 per patient 
for insulin initiation, with an additional £120–£162 for follow up per year (with an average of three 
follow-ups). This indicated existing variations in interventions and incentives, but it did not confirm 
which interventions were more effective.  
 
We investigated the public availability of diabetes LES intervention specifications and their evalua-
tions. The Contract Finder online tool (http://bit.ly/2M2Airs) requires commissioners to advertise 
contracts above £10 000, but the level of detail of planned interventions and evaluation vary and, 
being focused on the procurement opportunities, it does not provide the evaluation itself. The NICE 
Evidence Search has an option of searching practice-based information, but only one diabetes LES 
case study was available. Most of the results of an Internet search for “local enhanced service” and 
“diabetes” were planned services, with few reporting on concluded LESs and their outcomes. To 
gain an overview of diabetes LESs and their outcomes, 11 documents that were listed in an Internet 
search covering LESs from the UK in the last ten years were convenience sampled. This revealed a 
variety of purposes for LESs in diabetes care and services including: 
• Insulin initiation and follow-up (with payments ranging from £110 to £305 per patient for 
initiation and follow-up per year).  
• Care planning with diabetes annual review.  
• Longer appointments to complete eight care processes.  
• Dedicated protected diabetes clinic time, with one session to undertake the annual diabetes 
needs assessment and development of the agreed diabetes care and management plan.  
• Review of all patients managed by secondary care and discharge of patients not meeting the 
referral criteria.  
• Review of complex or sub-optimally treated diabetes patients.  
• Review of national and local developments by participating in local forums.  
• Participation in the National Diabetes Audit 
 
LESs for diabetes have been commissioned to address three themes: 1) to provide comprehensive 
community diabetes management for patients who would benefit from it (with the appropriate 
support from the specialist services); 2) to prevent diabetes complications; and 3) to support self-
management. We were interested to find out if, and how, a LES has been used to promote inte-
grated care (i.e. person-centred, coordinated care). Such a LES could shift care to primary care to 
encourage its continuity and provision close to home. This could include upskilling primary care 
healthcare professionals to make them more confident in treating individuals who would otherwise 
be referred to a specialist service. To make care more person-focused, a LES would help to protect 
primary care time and provide primary care clinicians with tools to improve engagement with pa-
tients to help better address their needs. 
 
Evaluation of existing LESs for diabetes  
 
In assessing the success of a LES, two key factors are taken into consideration: participation rates 
and the impact on health and financial outcomes. Of 11 diabetes LESs we reviewed, eight indicated 
a completed or planned evaluation and described it to a limited extent. The remaining three in-
cluded no evaluation strategy. Three CCGs could report the impact that the LES made, but neither 
the participation rates nor the financial impact were systematically reported.  
 
All three LES programmes made a positive impact in some or all areas of concern.  
• In Birmingham East and North PCT, all patients from secondary care who did not meet crite-
ria for referral were discharged to the LES participating practices (76 LES practices against 34 
non-LES practices; Choudhury, 2013). Diabetes clinics at these practices were funded to take 
place at least twice a year, with one session being an annual diabetes needs assessment and 
development of the agreed diabetes care and management plan. The LES practices were 
more likely to achieve glycaemic outcomes and less likely to refer to secondary care but 
there was no difference for blood pressure and lipids.  
• In West and South Yorkshire and Bassetlaw (2013), LES practices managed patients with di-
abetes on insulin/GLP-1 receptor agonist therapy. They were evaluated with regard to meet-
ing patients’ needs, maintaining clinical care close to home and being significantly more cost 
effective than running a similar service in secondary care.  
• In Greater Glasgow & Clyde (2010), the practice nurses in LES practices were responsible for 
an annual interview to screen for problems and support onward referral to appropriate ser-
vices that can provide ongoing support for individuals. Evidence of considerable progress in 
achieving more even distribution of intermediate clinical outcomes (cholesterol and BMI) 
was observed. 
 
These are promising results and commissioners considering improvements to diabetes care in other 
areas would benefit from knowing what has worked elsewhere. However, a simple adaptation of 
interventions that have been effective and efficient somewhere else may not guarantee success.  
 
In terms of primary care participation in LESs, it is important to understand the conditions that en-
courage practices to take on additional work. There are some general lessons to be shared from the 
literature on LESs: aligning a LES with an existing national framework may have positive spillover 
effects and increase LES activity; ensuring that the existing conditions of service provision support 
the requested activities may have an impact; and the size of the financial incentives may affect par-
ticipation (Kumar et al, 2014).  
 
Our review revealed other practices used by commissioners to encourage participation. Some rec-
ognised the importance of introducing eligibility criteria for participation in a LES (West and South 
Yorkshire and Bassetlaw Commissioning Support Unit, 2013). Another tactic was conducting a trans-
parent evaluation, referring to the LESs conducted in previous years and building a narrative of con-
tinuous improvement (NHS Greater Glasgow & Clyde, 2010).  
 
A LES can play an important role as a short-term catalyst for the development of a solution for a 
higher standard of care and better health outcomes (Kumar et al, 2014). However, there is no readily 
accessible information on what happens to practice when a LES is withdrawn or terminated, and 
whether the solutions having a positive impact are stopped by the providers or continue to be sup-
ported with the providers’ resources. This lack of evidence on the long-term impact of LESs can 
result in the halting of the previous LESs and a focus on spending any available financial resources 
on doing something new. As tempting as this may be, long-term thinking is needed to keep engage-
ment with service providers and provide a learning environment for continuous improvement. The 
questions to ask are:  
• Does the existing LES need replacing or rather improving/adjusting?  
• If it didn’t work, why?  
• Is the LES-supported activity still in place and effective after funding was withdrawn?  
• Could LESs be undertaken with fewer resources so more programmes are commissioned? 
 
Conclusion 
 
Significant resources have been spent in recent years on schemes aimed at improving diabetes care. 
A review of one such scheme, a LES for diabetes, revealed only a small number of reports with de-
tails of the interventions implemented and their evaluation. There may be several reasons for this. 
Commissioners designing and evaluating LESs locally, may not recognise the potential of mutual 
learning. Some LESs may lack evaluation altogether, as they are commissioned to fill short-term 
gaps, with no feedback or follow-up on the service provided. There is a missed opportunity to un-
derstand the effectiveness of this specific (locally motivated, voluntary and incentivised) commis-
sioning tool.  
 
To understand what impacts on the success of a LES, it is important to collect good data and use this 
internally and externally to learn lessons. Including requirements for data reporting and feedback 
in the LES specifications may motivate service providers to participate in evaluation. Putting out-
comes systematically in the public domain may help to build evidence that can be evaluated with 
best practice for an identified LES. For this to happen, a more systematic approach to data collection 
is needed, with description of:  
• The context of intervention – why was it introduced?  
• How the decision about the intervention was made – who initiated it and who was con-
sulted?  
• The interventions. 
• The eligibility criteria.  
• The participation rate and reasons for non-uptake.  
• The incentive, including what was being incentivised (activities and/or successful outcome) 
and when the incentive was rewarded (an initial start-up payment and/or a closing fee).  
• Outcomes.  
• Evaluation process.  
 
Having a single online point for depositing and accessing commissioned and evaluated LESs for dia-
betes would help to improve the practice of engaging in voluntary healthcare schemes and incen-
tivising better outcomes. NICE offers a platform with local practice case studies. Commissioners who 
wish to share their experience of NICE guidance and standards being used to change and improve 
local services can submit their examples to NICE for approval. Once quality assured, the case studies 
are published on the NICE website for others to learn from and adopt. Case studies can be submitted 
using the online submission form at http://bit.ly/2M9oL9P. 
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